Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BriaCell Taps FUJIFILM for Bria-IMT Manufacturing | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BriaCell Taps FUJIFILM for Bria-IMT Manufacturing

Deal supports Phase 3 development and potential commercial supply of breast cancer cell therapy.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

BriaCell Therapeutics Corp. has entered into a manufacturing arrangement with FUJIFILM Biotechnologies California to support the pivotal Phase 3 development of Bria-IMT and potential future commercial supply of the therapy.

Bria-IMT, BriaCell’s lead clinical candidate, is an off-the-shelf allogeneic cell therapy being evaluated in combination with an immune checkpoint inhibitor for advanced metastatic breast cancer.

“Securing manufacturing capacity with FUJIFILM, a global leader in cell therapy manufacturing, represents a key milestone in our Bria-IMT development and potential commercialization strategy as we work toward our goal of bringing this novel immunotherapy candidate to patients with metastatic breast cancer,” said William V. Williams, MD, President and CEO of BriaCell.

More FUJIFILM News

FUJIFILM Biotechnologies recently opened an expanded site in Teesside, UK.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics